Securities code: Blue Sail Medical Co.Ltd(002382) securities abbreviation: Blue Sail Medical Co.Ltd(002382) Announcement No.: 2022017 bond Code: 128108 bond abbreviation: lanfan convertible bond
Blue Sail Medical Co.Ltd(002382)
Announcement on the renewal of accounting firm
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
Blue Sail Medical Co.Ltd(002382) (hereinafter referred to as “the company”) held the 22nd Meeting of the 5th board of directors and the 20th meeting of the 5th board of supervisors on April 12, 2022, deliberated and adopted the proposal on renewing the appointment of the company’s audit institution in 2022. The company plans to continue to employ Ernst & Young Huaming Certified Public Accountants (special general partnership) (hereinafter referred to as “Ernst & Young Huaming”) as the company’s audit institution in 2022. This matter needs to be submitted to the general meeting of shareholders of the company for deliberation and approval. The relevant matters are hereby announced as follows:
1、 Description of the accounting firm to be reappointed
After the deliberation and approval of the third extraordinary general meeting of shareholders in 2021, the company hired an Yonghua Ming as the audit institution of the company in 2021. In the audit work in 2021, Ernst & Young Huaming followed the professional standards of independence, objectivity, impartiality and fairness, fulfilled its duties and provided high-quality audit services for the company. The report issued by Ernst & Young Huaming can objectively and truly reflect the actual situation, financial situation and operating results of the company, earnestly fulfilled the responsibilities of the audit institution and safeguarded the legitimate rights and interests of the company and shareholders from a professional perspective. In order to maintain the stability and continuity of the audit work, after careful study by the board of directors of the company, an Yonghua Ming will continue to be employed as the annual audit institution of the company in 2022 to audit the company and its subsidiaries for one year.
2、 Basic information of the accounting firm to be renewed
1. Institutional information
Ernst & Young Huaming Certified Public Accountants (special general partnership), established in September 1992, completed the localization transformation in August 2012 and transformed from a Sino foreign cooperative limited liability firm to a special general partnership firm. Ernst & Young Huaming is headquartered in Beijing and its registered address is room 01-12, 17th floor, Ernst & Young building, Oriental Plaza, No. 1, East Chang’an Street, Dongcheng District, Beijing.
2. Personnel information
By the end of 2021, it has 203 partners, and the chief partner is Mr. Mao Anning. An Yonghua Ming has always paid attention to talent training. By the end of 2021, it has 1604 certified public accountants, including more than 1300 certified public accountants with experience in securities related business services, and more than 400 certified public accountants who have signed the audit report of securities service business.
3. Business information
The total business income of Ernst & Young Huaming in 2020 was RMB 4.760 billion, including audit business income of RMB 4.589 billion (including securities business income of RMB 2.146 billion). In 2020, there were 100 annual report audit clients of A-share listed companies, with a total charge of RMB 824 million. The main industries of these listed companies involve manufacturing, finance, wholesale and retail, information transmission, software and information technology services, real estate, etc. The company has 44 audit clients of Listed Companies in the same industry.
4. Investor protection ability
Ernst & Young Huaming has good investor protection ability, and has withdrawn occupational risk fund and purchased occupational insurance in accordance with relevant laws and regulations, covering Beijing head office and all branches. The sum of the accrued occupational risk fund and the purchased occupational insurance cumulative compensation limit exceeds 200 million yuan. Ernst & Young Huaming has not borne any civil liability due to civil litigation related to practice in recent three years.
5. Independence and integrity record
Ernst & Young Huaming and its employees have not been subject to any criminal punishment or administrative punishment due to their professional behavior in recent three years, as well as the self-discipline supervision measures and disciplinary sanctions of self-discipline organizations such as stock exchanges and industry associations. It has twice received the decision of warning letter measures issued by the securities regulatory authority, involving 13 employees. The aforesaid decision to issue a warning letter is a supervisory and administrative measure, not an administrative penalty. According to the provisions of relevant laws and regulations, the supervision and management measures will not affect an Yonghua ming to continue to undertake or perform securities service business and other businesses.
3、 Project members
Project partner to be signed: Ms. Li Huihua
He became a certified public accountant in 2010, began to audit listed companies in 2010, began to practice at Ernst & Young Huaming in 2006, and provided audit services for the company from 2021; Annual reports / internal control audit reports of two listed companies have been signed in the past three years, involving industries including pharmaceutical manufacturing and software and information technology services.
Certified public accountant to be signed: Ms. Gao Jie
He became a certified public accountant in 2014, began to audit listed companies in 2015, began to practice at Ernst & Young Huaming in 2010, and provided audit services for the company from 2021; Signed the annual report / internal control audit report of a listed company in the past three years, involving non-metallic mineral products industry.
Reviewer of project quality control: Mr. Li Peng
He became a certified public accountant in 2004, began to audit listed companies in 2003 and began to practice at Ernst & Young Huaming in 2001. The annual reports / internal control audit reports of two listed companies have been signed in the past three years, including the medical industry.
2. Integrity record
In the past three years, the above project partners, quality control reviewers and signed certified public accountants have not been subject to criminal punishment due to their professional behavior, administrative punishment, supervision and management measures by the CSRC and its dispatched offices, industry competent departments, or self-discipline supervision measures and disciplinary sanctions by self-discipline organizations such as stock exchanges and industry associations.
3. Independence
Ernst & Young Huaming and the above project partners, project quality control reviewers and signed certified public accountants do not violate the independence requirements of the code of professional ethics for Chinese certified public accountants.
4. Audit fees
The audit remuneration paid by the company to Ernst & Young Huaming in 2021 is 2.1 million yuan. The specific audit fee for 2022 is proposed to be determined by the management authorized by the general meeting of shareholders of the company through consultation with the audit institution according to the actual business and market conditions of the company.
4、 Procedures to be performed by the accounting firm to be renewed
1. Performance of audit committee
The company held the 22nd Meeting of the audit committee of the Fifth Board of directors on April 12, 2022. The audit committee has reviewed an yonghuaming and believes that he adheres to the principle of independent audit, objectively, fairly and fairly reflects the company’s financial situation and operating results, earnestly performs the duties of the audit institution, and has the professional qualification and ability to be competent for the company’s audit in 2022, Agree to propose to the board of directors to renew the appointment of an Yonghua Ming as the company’s audit institution in 2022.
2. Prior approval opinions and independent opinions of independent directors
Prior approval opinion: we believe that Ernst & Young Huaming has strictly followed the independent auditing standards for Chinese certified public accountants and other laws, regulations and relevant policies related to financial audit during its tenure as the audit institution of the company in 2021, performed its duties diligently, followed the independent, objective and impartial practice standards, demonstrated good professional ethics and professional quality, and performed the responsibilities and obligations agreed by both parties. Therefore, It is agreed to submit the matter of renewing the appointment of an Yonghua Ming as the audit institution of the company in 2022 to the board of directors for deliberation.
Opinions of independent directors: after verification, Ann Wing Wah Ming has rich audit experience of listed companies and sufficient independence and professionalism. In the process of providing annual audit services for the company, he can be diligent and responsible, and give audit opinions fairly and objectively. The procedures for the company to renew the appointment of audit institutions comply with relevant laws, regulations and the provisions of Blue Sail Medical Co.Ltd(002382) articles of association, and there is no situation that damages the interests of the company and all shareholders, especially the interests of minority shareholders. Therefore, we agree to renew the appointment of an Yonghua Ming as the company’s audit institution in 2022 for one year, and agree to submit the matter to the general meeting of shareholders of the company for deliberation. 3. Deliberation and voting of the board of directors
On April 12, 2022, the company held the 22nd Meeting of the 5th board of directors. The meeting considered and adopted the proposal on renewing the appointment of the company’s audit institution in 2022 with 6 affirmative votes, 0 negative votes and 0 abstention votes.
4. Effective date
The matter of renewing the appointment of the audit institution in 2022 needs to be submitted to the general meeting of shareholders of the company for deliberation and effective from the date of deliberation and approval by the general meeting of shareholders of the company.
5、 Documents for future reference
1. Resolutions of the 22nd Meeting of the 5th board of directors of the company;
2. Resolutions of the 22nd Meeting of the audit committee of the 5th board of directors of the company;
3. Resolutions of the 20th meeting of the 5th board of supervisors of the company;
4. Prior approval opinions and independent opinions of independent directors;
5. Relevant supporting materials of Ernst & Young Huaming Certified Public Accountants (special general partnership) and the signing certified public accountant. It is hereby announced.
Blue Sail Medical Co.Ltd(002382) board of directors
April 13, 2002
